Singular Genomics Systems Inc Asset Turnover Ratio (OMIC), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Singular Genomics Systems Inc   (NASDAQ: OMIC)
 

Singular Genomics Systems Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Singular Genomics Systems Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the third quarter (Sep 30 2024)

Within sector 4 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2024, to 1546, from total ranking in the second quarter 2024 at 3680.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OMIC Asset Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Asset Change -34.36 % -22.31 % -21.54 % -18.87 % -17.55 %
Y / Y Revenue Change -12.12 % 45.94 % -48.78 % 41.31 % -
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
OMIC's Total Ranking # 1546 # 3680 # 3833 # 1231 # 3694
Seq. Asset Change -15.21 % -7.99 % -9.93 % -6.6 % 0.37 %
Seq. Revenue Change -44.91 % 66.74 % -59.11 % 133.98 % -8.51 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 158
Overall Market # 1546

Asset Turnover Ratio Statistics
High Average Low
11.53 8.62 7.07
(Dec 31 2023)   (Jun 30 2024)




OMIC Company Profile • Back to OMIC Efficiency Comparisons • Compare OMIC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Uniqure N v   0.04 $ 28.587  Millions$ 744.598  Millions
Therapeuticsmd Inc   0.04 $ 1.517  Millions$ 40.778  Millions
Intellia Therapeutics Inc   0.03 $ 43.086  Millions$ 1,231.363  Millions
Abvc Biopharma Inc   0.03 $ 0.524  Millions$ 15.037  Millions
Verve Therapeutics Inc   0.03 $ 24.396  Millions$ 712.465  Millions
Seer Inc   0.03 $ 14.046  Millions$ 412.066  Millions
Orgenesis Inc   0.03 $ 0.899  Millions$ 26.434  Millions
Envoy Medical Inc   0.03 $ 0.278  Millions$ 8.221  Millions
Bioxcel Therapeutics Inc   0.03 $ 2.276  Millions$ 67.588  Millions
Astrotech Corp  0.03 $ 1.273  Millions$ 38.781  Millions
Orchestra Biomed Holdings Inc   0.03 $ 2.647  Millions$ 81.386  Millions
Tscan Therapeutics Inc   0.03 $ 9.362  Millions$ 308.970  Millions
Agios Pharmaceuticals Inc   0.03 $ 32.871  Millions$ 1,087.921  Millions
Caribou Biosciences Inc   0.03 $ 11.475  Millions$ 389.077  Millions
Blue Water Vaccines Inc  0.03 $ 1.871  Millions$ 70.983  Millions
Fate Therapeutics Inc   0.03 $ 13.447  Millions$ 524.974  Millions
Biorestorative Therapies Inc   0.02 $ 0.379  Millions$ 15.314  Millions
Proqr Therapeutics N v   0.02 $ 4.222  Millions$ 179.692  Millions
Therapeutic Solutions International Inc   0.02 $ 0.085  Millions$ 3.679  Millions
Abcellera Biologics Inc   0.02 $ 32.962  Millions$ 1,439.125  Millions
Cardiff Oncology Inc   0.02 $ 1.615  Millions$ 71.156  Millions
Janux Therapeutics Inc   0.02 $ 13.049  Millions$ 613.956  Millions
Dianthus Therapeutics Inc   0.02 $ 6.811  Millions$ 321.268  Millions
Polomar Health Services, Inc.  0.02 $ 0.055  Millions$ 2.639  Millions
Roivant Sciences Ltd   0.02 $ 125.677  Millions$ 6,809.409  Millions
Absci Corp  0.02 $ 4.207  Millions$ 245.739  Millions
Immunitybio inc   0.02 $ 7.332  Millions$ 428.507  Millions
Aclarion Inc   0.02 $ 0.049  Millions$ 3.116  Millions
Lexicon Pharmaceuticals Inc   0.02 $ 5.252  Millions$ 335.282  Millions
Pluri Inc   0.02 $ 0.598  Millions$ 38.231  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.